Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time

ClinicalTrials.gov ID: NCT05362058

Public ClinicalTrials.gov record NCT05362058. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 9:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Parallel-Design, Open-Label, Randomized Control Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared to Insulin Degludec in Insulin Naïve Adults With Type 2 Diabetes

Study identification

NCT ID
NCT05362058
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
928 participants

Conditions and interventions

Interventions

  • Insulin Degludec Drug
  • Insulin Efsitora Alfa Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2, 2022
Primary completion
Apr 9, 2024
Completion
Apr 9, 2024
Last update posted
May 15, 2025

2022 – 2024

United States locations

U.S. sites
30
U.S. states
19
U.S. cities
30
Facility City State ZIP Site status
Neighborhood Healthcare Institute of Health Escondido California 92025
Valley Research Fresno California 93720
NorCal Medical Research, Inc Greenbrae California 94904
Catalina Research Institute, LLC Montclair California 91763
Southern California Dermatology, Inc. Santa Ana California 92701
New West Physicians Clinical Research Golden Colorado 80401
New England Research Associates, LLC Bridgeport Connecticut 06606
East Coast Institute for Research, LLC Jacksonville Florida 32204
East Coast Institute for Research - Canton Canton Georgia 30114
Rophe Adult and Pediatric Medicine/SKYCRNG Union City Georgia 30291
Central Illinois Diabetes and Clinical Research a Division of Prairie Education and Research Cooperative Springfield Illinois 62711
Qualmedica Research, LLC Evansville Indiana 47715
Iowa Diabetes and Endocrinology Research Center West Des Moines Iowa 50265
Qualmedica Research Bowling Green Kentucky 42101
MedStar Health Research Institute (MedStar Physician Based Research Network) Hyattsville Maryland 20782
Endocrine and Metabolic Consultants Rockville Maryland 20852
SKY Clinical Research Network Group-Quinn Ridgeland Mississippi 39157
Clinvest Research LLC Springfield Missouri 65807
Clarity Clinical Research East Syracuse New York 13057
Great Lakes Medical Research, LLC Westfield New York 14787
Monroe Biomedical Research Monroe North Carolina 28112
Lucas Research, Inc Morehead City North Carolina 28557
Intend Research, LLC Norman Oklahoma 73069
Jefferson Clinical Research Institute (JCRI) Philadelphia Pennsylvania 19114
Tribe Clinical Research, LLC Greenville South Carolina 29607
Dallas Diabetes Research Center Dallas Texas 75230
Juno Research Houston Texas 77040
Southern Endocrinology Associates Mesquite Texas 75149
North Hills Family Medicine/North Hills Medical Research North Richland Hills Texas 76180
Multicare Institute for Research and Innovation Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 83 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05362058, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 15, 2025 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05362058 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →